Derailed B cell homeostasis in patients with mixed connective tissue disease

Human Immunology

Volumn 74, Issue 7, 2013, Pages 833-841

  Hajas, A ^a   Barath, S ^a   Szodoray, P ^b   Nakken, B ^b   Gogolak, P ^a   Szekanecz, Z ^a   Zold, E ^a   Zeher, M ^a   Szegedi, G ^a   Bodolay, E ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN D; METHOTREXATE;

ADULT; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CELL POPULATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; MALE; MEMORY CELL; MIXED CONNECTIVE TISSUE DISEASE; PERIPHERAL CIRCULATION; PLASMA CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ANTIGENS, CD; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; CELLS, CULTURED; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; HOMEOSTASIS; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; METHOTREXATE; MIXED CONNECTIVE TISSUE DISEASE; PLASMA CELLS; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR;

EID: 84878571051     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.04.007     Document Type: Article

References (43)

1. Sharp G.C., Irvin W.S., Tan E.M., Jolla L., Gould G.R., Holmand H.R. Mixed connective tissue disease; an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972, 52:148-149.
2. Reichlin M., van Venrooij W.J. Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis. Clin Exp Immunol 1999, 83:286-290.
3. Fujinami M., Saito K., Okawa-Takatsuji M., Kotajina L., Kinoshitar M., Sumiya M., et al. Histological evaluation of destructive monoarthropathy in mixed connective tissue disease. Scand J Rheumatol 1997, 26:395-398.
4. Ortega-Hernandez O.D., Shoenfeld Y. Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheum 2012, 26:61-72.
5. Hoffman R.W., Maldonado M.E. Immune pathogenesis of mixed connective tissue disease. A short analytical review. Clin Immunol 2008, 128:8-17.
6. Maldonado M.E., Perez M., Pignac-Kobinger J., Marix E.T., Tozman E.M., Greidinger E.L., et al. Clinical and immunological manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population. J Rheumatol 2008, 35:429-437.
7. Gunnarsson R., Molberg O., Gilboe I., Gran J.T. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. PAHNOR1 study group. BMJ 2011, 70:1047-1051.
8. Bodolay E., Szekanecz Z., Devenyi K., Csipo I., Végh J., Garai I., et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatol (Oxford) 2005, 44:656-661.
9. Swanton I., Isenberg D. Mixed connective tissue disease: still crazy after all these years. Rheum Dis North Am 2005, 31:421-436.
10. Greidinger E.L., Hoffman R.W. Autoantibodes in the pathogenesis of mixed connective tissue disease. Rheum Dis North Am 2005, 31:437-450.
11. Tan E.M. Antinuclear antibodies, diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989, 44:93-120.
12. Lundberg I., Hedfords E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. J Rheumatol 1991, 18:1511-1519.
13. Keith M.P., Moratz C., Tsokos G.C. Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease. Autoimmun Rev 2007, 6:232-236.
14. Hoffman R.W., Maldonado M.E. Immune pathogenesis of mixed connective tissue disease: a short analytical review. Clin Immunol 2008, 128:8-17.
15. Alarcon-Segovia D., Villarreal M. Classification diagnostic criteria for mixed connective tissue disease. Mixed connective tissue disease and anti-nuclear antibodies 1987, 33-40. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division). R. Kasukawa, G.C. Sharp (Eds.).
16. Weening J.J., D'Agati V.D., Schwartz M.M., Seshan S.V., Alperts C.E., Appel G.B., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004, 15:241-250.
17. Takada K., Suzuki K., Matsumoto M., Okada M., Nakanishi T., Horikoshi H., et al. Clinical characteristics of patients with both anti-U1RNP and anti-centromere antibodies. Scand J Rheumatol 2008, 37:360-364.
18. Benito-Garcia E., Schur P.H., Lahita R. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests. Arthritis Rheum 2004, 54:1030-1044.
19. Hassan B.A., Rönnelid J., Gunnarsson I., Karlsson G., Berg L., Lundberg I. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease. J Autoimunity 1998, 11:503-508.
20. Odendahl M., Jacobi A., Hansen A., Feist E., Hiepe F., Burmes G.R., et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000, 165:5970-5979.
21. Hansen A., Odendahl M., Reiter K., Jacobi A.M., Feist E., Scholze J., et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002, 46:2160-2171.
22. Wei C., Anolik J., Cappione A., Zheng B., Pugh-Bernard A., Brooks J., et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 2007, 178:6624-6633.
23. Jacobi A.M., Reiter K., Mackay M., Aranow C., Hiepe F., Radbruch A., et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum 2008, 58:1762-1773.
24. Wehr C., Kivioja T., Schmitt C., et al. The EUROclass trial defining subgroups in common variable immunodeficiency. Blood 2008, 111:77-85.
25. Yong P.L., Orange I.S., Sullivan K.E. Pediatric common variable immunodeficiency: immunologic and phenotypic associations with switched memory B cells. Pediat Allergy Immunol 2010, 5:852-858.
26. Potter K.N., Mockridge C.I., Rahman A. Disturbances in peripheral blood B cell subpopulations in autoimmune patients. Lupus 2002, 11:872-877.
27. Jung J., Choe J., Li L., Choi Y.S. Regulation of CD27 expression in the course of germinal center B cell differentiation: the privotal role of IL-10. Eur J Immunol 2000, 30:2437-2443.
28. Bodolay E., Aleksza M., Antal-Szalmás P., Végh J., Szodoray P., Soltész P., et al. Serum cytokine levels, type 1 and intracellular T cell cytokine profiles in mixed connective tissue disease. J Rheumatol 2002, 29:2136-2142.
29. Lipsky P.E. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001, 2:764-766.
30. Chan O.T., Madaio M.P., Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999, 169:107-121.
31. Salomonsson S., Jonsson M.V., Skarstein K., Brokstad K.A., Hjelmstrom P., Wahren-Herlenius M., et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003, 48:3187-3201.
32. Marston B., Palanichami A., Anolik J.H. B cells in the pathogenesis and treatment of rheumatoid arthritis. Curr Opin Rheumatol 2010, 22:307-315.
33. Sato S., Fujimoto M., Hasegawa M., Takehara K., Tedder T.F. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. Mol Immunol 2004, 41:1123-1133.
34. Anolik J.H., Barnard J., Cappione A., Pugh-Bernard A.E., Felgar R.E., Looney R.J., et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 2004, 50:3580-3590.
35. Illei G.G., Tackey E., Laptevas L., Lipsky P.E. Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. Arthritis Rheum 2004, 50:1709-1720.
36. Arce E., Jackson D.G., Gill M.A., Bennett L.B., Bancherean J., Pascual V. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with Systemic Lupus Erythematosus. J Immunol 2001, 167:2361-2369.
37. Lee J., Kuchen S., Fischer R., Chang S., Lipsky P.E. Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol 2009, 182:4116-4126.
38. Sims G.P., Ettinger R., Shirota Y., Yarboro C.H., Illei G.G., Lipsky P.E. Identification and characterization of circulating human transitional B cells. Blood 2005, 105:4390-4398.
39. Morbach H., Eichhorn E.M., Liese J.G., Girschick H.J. Reference values for B cell subpopulations from infancy to adults. Clin Exp Immunol 2010, 162:271-279.
40. Cuss A.K., Avery D.T., Cannons J.L., Yu L.J., Nichols K.E., Shaw P.J., et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 2006, 176:1506-1516.
41. Sanz I., Wei C., Lee F.E., Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 2008, 20:67-82.
42. Rodriguez-Bayona B., Ramos-Amay A., Perez-Venegas J.J., Rodríguez C., Brieva J.A. Decreased frequency activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients. Arthritis Res Ther 2010, 12:R108.
43. Jacobi A.M., Obendahl M., Reiter K., Bruns A., Burmester G.R., Radbruch A., et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2003, 48:1332-1342.